BRS Movement Disorders 2015_no videos
Transcript of BRS Movement Disorders 2015_no videos
D A N I S H B H A T T I M DM O V E M E N T D I S O R D E R S D I V I S I O N
MOVEMENTDISORDERS!D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
OUR INTENTIONS:THIS TALK
IS MEANT TOD B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
T H I N G S W E ’ R E D I S C U S S I N G F O R N E X T 5 6 M I N U T E S :
FU N CT I O N A L A N ATO MYPA RK I N SO N I SM
E SSE N T I A L TRE MO RDYS TO N I A S
C HO RE A S A N D HDT I CS A N D TO U RE TTE
C HE MO DE N E RVAT I O NDE E P B RA I N S T I MU L AT I O N
RE V I E W V I DE O S
T H I N G S W E ’ R E D I S C U S S I N G F O R N E X T 5 6 M I N U T E S :
FU N CT I O N A L A N ATO MYPA RK I N SO N I SM
E SSE N T I A L TRE MO RDYS TO N I A S
C HO RE A S A N D HDT I CS A N D TO U RE TTE
C HE MO DE N E RVAT I O NDE E P B RA I N S T I MU L AT I O N
RE V I E W V I DE O S
T H I N G S W E ’ R E D I S C U S S I N G F O R N E X T 5 6 M I N U T E S :
FU N CT I O N A L A N ATO MYPA RK I N SO N I SM
E SSE N T I A L TRE MO RDYS TO N I A S
C HO RE A S A N D HDT I CS A N D TO U RE TTE
C HE MO DE N E RVAT I O NDE E P B RA I N S T I MU L AT I O N
RE V I E W V I DE O S
T H I N G S W E ’ R E D I S C U S S I N G F O R N E X T 5 6 M I N U T E S :
FU N CT I O N A L A N ATO MYPA RK I N SO N I SM
E SSE N T I A L TRE MO RDYS TO N I A S
C HO RE A S A N D HDT I CS A N D TO U RE TTE
C HE MO DE N E RVAT I O NDE E P B RA I N S T I MU L AT I O N
RE V I E W V I DE O S
T H I N G S W E ’ R E D I S C U S S I N G F O R N E X T 5 6 M I N U T E S :
FU N CT I O N A L A N ATO MYPA RK I N SO N I SM
E SSE N T I A L TRE MO RDYS TO N I A S
C HO RE A S A N D HDT I CS A N D TO U RE TTE
C HE MO DE N E RVAT I O NDE E P B RA I N S T I MU L AT I O N
RE V I E W V I DE O S
T H I N G S W E ’ R E D I S C U S S I N G F O R N E X T 5 6 M I N U T E S :
FU N CT I O N A L A N ATO MYPA RK I N SO N I SM
E SSE N T I A L TRE MO RDYS TO N I A S
C HO RE A S A N D HDT I CS A N D TO U RE TTE
C HE MO DE N E RVAT I O NDE E P B RA I N S T I MU L AT I O N
RE V I E W V I DE O S
T H I N G S W E ’ R E D I S C U S S I N G F O R N E X T 5 6 M I N U T E S :
FU N CT I O N A L A N ATO MYPA RK I N SO N I SM
E SSE N T I A L TRE MO RDYS TO N I A S
C HO RE A S A N D HDT I CS A N D TO U RE TTE
C HE MO DE N E RVAT I O NDE E P B RA I N S T I MU L AT I O N
RE V I E W V I DE O S
T H I N G S W E ’ R E D I S C U S S I N G F O R N E X T 5 6 M I N U T E S :
FU N CT I O N A L A N ATO MYPA RK I N SO N I SM
E SSE N T I A L TRE MO RDYS TO N I A S
C HO RE A S A N D HDT I CS A N D TO U RE TTE
C HE MO DE N E RVAT I O NDE E P B RA I N S T I MU L AT I O N
RE V I E W V I DE O S
T H I N G S W E ’ R E D I S C U S S I N G F O R N E X T 5 6 M I N U T E S :
FU N CT I O N A L A N ATO MYPA RK I N SO N I SM
E SSE N T I A L TRE MO RDYS TO N I A S
C HO RE A S A N D HDT I CS A N D TO U RE TTE
C HE MO DE N E RVAT I O NDE E P B RA I N S T I MU L AT I O N
RE V I E W V I DE O S
T H I N G S W E ’ R E D I S C U S S I N G F O R N E X T 5 6 M I N U T E S :
FU N CT I O N A L A N ATO MYPA RK I N SO N I SM
E SSE N T I A L TRE MO RDYS TO N I A S
C HO RE A S A N D HDT I CS A N D TO U RE TTE
C HE MO DE N E RVAT I O NDE E P B RA I N S T I MU L AT I O N
RE V I E W V I DE O S
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
N O V E M B E R 1 8 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
TREMORD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
Oscillatorymovementcausedbythealternatingactivationofagonist/antagonistmusclegroups.Canbemostlyatrest(parkinsonian),withaction(EssentialTremor)
andmanyothersubtypes.
CHOREAD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
(fromGreekwordfordance)fast,jerky,involuntarymovementsthatflowrandomlyfromonebodyparttothenextone.
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
DYSTONIAD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
excessivemusclecontractionthatcausesabnormalmovementsorpostures.
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
MYOCLONUSD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
veryfast,jerky,shock-likeinvoluntarymovements
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
TICSD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
abrupt,oftenrepetitive,suddenmovementsorvocalizationsthatareprecededbyanuncomfortablefeelingthatisrelievedbytheact.Whilesuppressingthetics,
thereisabuildingupoftheinternalpressuretoletgo.
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
AKATHISIAD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
Aninabilitytostaystill.Thereisaninternalneedtomoveconstantly,butthesearevoluntarymovementsthataresuppressible.
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
STEREOTYPYD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
voluntarystereotypicalmovementsthatareperformedusuallysemiconsciously,morecommonduringalertself-wanderingorunderstress.Usuallynot
pathological,althoughacommonfeatureindevelopmentaldelayandautism.
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
PREVALANCE OF MOVEMENT DISORDERS
MORE THAN THOUSAND CONDITIONS10% LIFE TIME RISK OF ESSENTIAL TREMOR
10% POPULATION WITH RLS4% RISK OF PARKINSON DISEASE
4% POPULATION WITH TOURETTE SYNDROME1-4% RISK OF ATAXIAS
IMPORTANCE OF MOVEMENT DISORDERS
SOME ARE CURABLE BUT ALL ARE TREATABLEMANY GOOD TREATMENT OPTIONS:
CHEMODENERVATION, DEEP BRAIN STIMULATIONTREATMENT IMPROVES QUALITY OF LIFE
FREQUENTLY MISDIAGNOSED OR UNDIAGNOSED
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
CLASSIFICATION OF MOVEMENT DISORDERS
HYPOKINETICHYPERKINETIC
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D C E M E B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
FUNCTIONAL ANATOMYD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
FUNCTIONAL ANATOMYD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
DIRECT AND INDIRECT PATHWAYSD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
PARKINSONISMPresenceoftwoofthecardinalfeaturesmakesthediagnosis,butat
leastonehastobeamajorfeature.Majorfeaturesincludebradykinesia,restingtremor,rigidityandpostural
instability.Otherfeatures:Rigidity,flexedposture,lossofposturalreflexes,
freezing.
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
PARKINSONISMPresenceoftwoofthecardinalfeaturesmakesthediagnosis,butat
leastonehastobeamajorfeature.Majorfeaturesincludebradykinesia,restingtremor,rigidityandpostural
instability.Otherfeatures:Rigidity,flexedposture,lossofposturalreflexes,
freezing.D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
PARKINSONISMPresenceoftwoofthecardinalfeaturesmakesthediagnosis,butat
leastonehastobeamajorfeature.Major featuresincludebradykinesia,restingtremor,rigidityandpostural
instability.Otherfeatures:Rigidity,flexedposture,lossofposturalreflexes,
freezing.D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
PARKINSONISM: CLASSIFICATIONPRIMARY
IDIOPATHICPARKINSON-PLUS
SYNDROMESMSAPSP
CBGDDLB
SECONDARYMEDICATION INDUCED
TUMORTRAUMATICINFECTIOUS
PARKINSONISMD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
PARKINSONISMD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
PARKINSONISMD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
GENETICS OF PARKINSONS
CAUSAL GENESASSOCIATED GENES
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C M E B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
MonoGenicParkinson’sDisease:PARK1-9
PARK1/PARK4:Abnormala-synculein gene,AD,earlyonsetoftypicalPDbeforeage50
PARK8:LRRK2 genemutation,ADorsporadic,mostfrequentcauseoflateonsetPD,typicalPD,manydozensofmutations,ethnicallyspecificmutationsinarabs,jewish andeuropeans.
PARK2:Parkin genemutation,AR,MostcommoncauseofJuvenilePD(<21yearsage),usuallypresentsmidtolateonsettypicalPD.
PARK6:Pink1genemutation,AR,undistinguishablefromotherPD
PARK7:DJ1genemutation
PARK9:ATP13a2genemutation
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
NEURO-LEPTICNEURO-TOXICITY
NEUROLEPTICMALIGNANTSYNDROME:
lifethreateningMostcommonlyseenwithinitiationanddosechangesHyperthermia, rigidity,mentalstatuschanges,highCPK.Stopdrug, Rxwith levodopa.
AKATHISIAAcuteorTardive
Restlessness
PARKINSONISMfromDA2receptorblockade.
MostresolveafterW/D
TARDIVEDYSKINESIAfromchronicDAreceptorblockadeFacialand lingual stereotypic, repetitive, rhythmicinvoluntarymovements,+/- otherchorea,dystonia, tics,andmyoclonus
Rx:Discontinuedrug (acuteworsening),GABA, DA-depleters, Chemodenervation.
Prognosis: About20%resolve,most respond toRx.
ACUTEDYSTONICREACTION
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
MONOGENIC PARKINSONS
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
MONOGENIC PARKINSONS
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
ASSOCIATED GENES
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
ASSOCIATED GENES
a-Synuclein gene Most significant risk factor is the variation in the actual a-synculein gene itself.
Some variations cause monogenic parkinsonswhile others increase risk of PD.
LRRK 2 gene Some mutations can cause monogenic PDVariations in LRRK 2 gene increased risk of PDMost common known genetic risk factor for PDAs common as 40% of the patients with PD
B - Gluco-cerebrosidase
Homozygous mutation causes Gauchers disease
Heterozygous mutation increases risks for PD (5 times more likely than general population).People with GBA mutation develop PD at younger age.
TREATMENTD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
Avoidantiemetics andantipsychotics.Onlysafeantiemetics areOndansetronandDomperidone.
Onlysafeanti-psychoticsareSeroquelandClozapine.Youngpatientwithminorsymptoms:Rasagiline (MAOi),Pramipexole andRopinirole
(dopa-agonists)>50yo and/orwithmorethanmildseverity=Levodopa
Sideeffectsfortheexam:Psychosis,orthostasisAgonists:Sleepattacks,OCD,gambling,cognitive.
Levodopa:dyskinesias,nausea.
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
MSAPA R K IN SO N ISM
AU TO N O MIC DYSFU N C TIO NATA X IA
PY R A MIDA L SIG N SG LIA L C Y TO PLA SMIC IN C LU SIO N S
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
PSPA X I A L PA R K I N S O N I S M
S U P R A N U C L E A R PA L S YD E M E N T I A
P S E U D O BU L BA R S Y M P TO M SB R A I N S T E M N E U RO F I B R I L A RY TA N G L E S
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
CBGDA X I A L PA R K I N S O N I S MC O R T I C A L F E AT U R E S
AG N O S I A , A P R A X I A , A L I E N L I M BDYS TO N I A
P O O R L E VO D O PA R E S P O N S EBA LO O N E D H Y P O C H RO M AT I C N E U RO N S
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M E B R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
DEEP BRAIN STIMULATION SURGERY
DBShasproventobebeneficialtoanumberofconditions,includingPD,Essentialtremor,andDystonia
Morethan100,000patientshavereceivedaDBSdeviceProventoimprovequalityoflifePracticalcureforEssentialTremor
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
ESSENTIAL TREMORD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
Benign,FamilialEssentialTremorNotthatbenign:associatedwithcoordinationproblems,hearingloss,
andgaitinstability;canprogresstobecomedisablingHighlytreatable,butincrediblyunder-diagnosed
Oralmedications:Primidone,Propranolol,Topiramate.DeepBrainStimulationisapracticalcureinmorethan90%ofpatients
resistanttomedications
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
GESTE ANTAGONISTE
Torticollis to right, laterocollis to the right, right shoulder elevation
Light touch of the hand on the chin allows the head to return to the foreword position.
CLASSIFICATION OF DYSTONIAETIOLOGY
PRIMARY:Genetic(DYT-#)oridiopathicSECONDARY:otherknowndiseases(PD,HD,SCA3,NBIA,Wilson’s,etc),medications,
AGEEARLYONSET:Youngerthan27yo.
LATEONSET:Olderthan27.ANATOMICAL
Focal,segmental,multifocal,hemidystonia,generalized.TIME
Constant,intermittentorsituational.
DYSTONIAOnefootdragging
Tip-toeorin-toeingambulationMusclespasms
Severestiffness(neck,arm,leg)Excessiveeyeclosure(called
blepharospasm)Uncontrollablemovements
(hand,face)
Inabilitytousethehand,withoutweakness(writer’scramp)
Voiceabnormality(spasmodicdysphonia)Tremor
Abnormalpostures(torticollis)
TREATMENTD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
ORALDRUGSAnticholinergics,Gabaergics (bothAandB)anddopaminergicagents,usually
acombinationofmultipledrugsatmoderatedose.Everydystonicpatientshouldbeconsideredforlevodopareplacement
(Dopa-responsivedystonias)CHEMODENERVATION:Botulinumtoxininjections.
SURGERYDeepBrainStimulationorlesional surgery:Globuspallidus parsinterna.
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
TREATMENTD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
Chemodenervationduetolackofreleaseofacetylcholineatnervemusclejunction.
Thistoxindisruptproteincomplexcriticalfusionofacetylcholinecontainingvesiclewithcellmembrane
Thetoxinsbindstothesurfacereceptorsandthereinternalizethroughendosomesandreleasedtocytoplasmand
Toxinbindstoandcleaveproteininvolvedinendosomefusionwithmembrane.
7botulinumtoxinserotypesfromAtoG.
TypeAandEcleaveSNAP-25 (synaptosomal associatedprotein25).
TypesB,D,FandGcleaveVAMP (vesiclesassociatedmembraneprotein).
TypeCtoxincleavesbothSYNTAXIN andSNAP-25.
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
TREATMENTD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
NEUROLEPTIC NEUROTOXICITYD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
NEUROLEPTICMALIGNANTSYNDROMElifethreatening
MostcommonlyseenwithinitiationanddosechangesHyperthermia,rigidity,mentalstatuschanges,highCPK.
Stopdrug,Rxwithlevodopa.ACUTEORTARDIVEAKATHISIA
PARKINSONISMfromDA2receptorblockade.MostresolveafterW/D.
TARDIVEDYSKINESIAfromchronicDAreceptorblockade
Facialandlingualstereotypic,repetitive,rhythmicinvoluntarymovements,+/- otherchorea,dystonia,tics,andmyoclonus
Rx:Discontinuedrug(acuteworsening),GABA,DA-depleters,Chemodenervation.Prognosis:About20%resolve,mostrespondtoRx.
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
ACUTE DYSTONIC REACTIOND A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
AssociatedwitharatheracutestateofDAdeficiency.(administrationofDAblockersorwithdrawalfromDAagonists).
Oculo-gyric crisisareusuallyaccompaniedwithopisthotonus,rigidity,rageorfear,catalepsyorblock.UsualtreatmentisBenadrylorBenztropine (anti-ACh),
withresponsewithinanhour.
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
SEROTONIN SYNDROMESS NMS
Offending drug 5HT and DA excess DA deficiencyOnset to peak time Hours DaysResolution < 24 hrs Days to weeksHyperthermia 45% > 90%Altered LOC 50% > 90 %Autonomic DysFx 50-90% > 90 %Rigidity 50% > 90 %Leukocytosis 11% > 90 %Increased CPK 15% > 75%Hyperreflexia Very common RareMyoclonus Very common RareDA-agonists Exacerbate Improve
TIC DISORDERSD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
Transientticdisorder(<1yearduration)-24%ofchildren.
Chronicticdisorder(>1yearduration)- motororvocalbutnotboth.
Tourettesyndrome(1- 3.5%ofchildren)
MultiplemotorandatleastonevocalticWaxingandwaningcourseoveratleast1year
Onsetbefore21(usually6-7yearsold)Absenceofprecipitatingdisease
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
TOURETTE SYNDROMEObsessive-compulsive disorder
30-70%
Attention deficit disorder 50-75%
Anxiety disorders 20-80%
Mood disorders 20-80%
Episodic control disorders 25%
Academic difficulties 50%
D A N I S H B H AT T I M DM O V E M E N T D I S O R D E R S C o .
TOURETTE SYNDROMECommon:atleasttwopeopleinthisroomhasit.
Sociallyisolating,althoughhighlytreatable.Runsinfamilies,withoutcleargeneticpattern.
COPROLALIA:Utteranceoffoullanguageisuncommon (10%)
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
CHOREAHuntingtondiseaseSydenhamchorea(rheumaticchorea)
Drug-induced(dopaminergicagents,opiates)
LupuserythematosusThyroiddisease
ChoreagravidarumSecondarytoother
neurodegenerativediseases(Wilson’s,NBIA,SCA-3).
Hemiballismus:Sudden,wide-amplitudechorea,
usuallyduetostrokeofthestriatum>>Sub-thalamicnucleus.
HUNTINGTON DISEASED A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
Autosomaldominantdisorder.(4p16.3)Characterizedbyprogressivecognitiveandpsychiatricchanges,choreaandgait
problems(ataxia,falls)40,000peopleintheU.S.haveHD
About250,000peopleareat-riskforHDEqualratiobetweenmenandwomen
Insidiousprogressivecoursewithdeath15-20yearsafteronset.ChoreacanbetreatedwithRespridal,Tetrabenazine (DAdepleter)althoughis
associatedwithsuicidality.Treatdepression,irritabilityasusual.
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
Main Features of HDMotor function Falls and balance problems
Involuntary movements (chorea)Gait impairmentProblems swallowingOcular movement abnormalities
Cognitive Forgetfulness – Dementia – lack of focus and concentrationPoor judgment.Difficulty learning new informationInability to reason and planning (prioritizing, organizing)
Psychiatric Fast emotional shifts, impassivity. Depression (30-50% risk)Personality change (irritability, anger, apathy, etc.)Psychosis (10% lifetime risk)Increased risk for suicide (As many as 25 % attempt suicide)
RESTLESS LEG SYNDROMED A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
Acreepy/crawlysensationusuallyintheLEthatgoesawaybymoving,walking.Rarelygeneralized.
OnofthemostcommonMovementDisorders.Mostcommonatnight.
Primaryorsecondary(parkinsonism,neuropathy,renaldysfunction)Canbeassociatedwithanemia(irondeficiency).
Highlytreatable:responsivetodopamineagonistsandlevodopa.Goodprognosis.
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
ATAXIAD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
Themostcommoncauseofataxiaistoxic(medications,ETOH)ACUTE
stroke,drugs,hydrocephalus,migraine(inchildren),infectious(VZV)SUBACUTE
tumors,post-infectious,vasculitis,drugsCHRONIC
alcoholism,drugs,paraneoplastic,Multiplesclerosis.
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
HEREDITARY ATAXIASD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
N O V E M B E R 1 8 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
Difficulttodistinguish,soIalwaysobtaintheataxiacompletepanel(Friedrich,DRPLA,commonSCA’s).Alwaysruleoutsecondaryandtreatablecausesfirst:mass,infection,Wilson,metabolic.
SCA’s=dominant.FA,Edef,A-betalipoprot,AT=recessiveVisualloss?à SCA7.Seizures?à SCA10.Chorea?à DRPLA
Parkinsonism?à SCA2,3,21Olderadult?à SCA6
Childhoodonset?à SCA7,13,DRPLA
MYOCLONUSD A N I S H B H AT T I M D
M O V E M E N T D I S O R D E R S C o .
Physiologic- hiccups,sleepEpileptic- cortical,isatypeofseizure
Essential- subcortical,familial,childhoodonset,benigncourse.Symptomatic(secondary)- metabolic(hepaticfailure,uremia,hypoxia),
degenerative(Alzheimer’s),infectious(priondiseases)Spinal- segmentalorfocal.
Asterixis- Negativemyoclonus
D B V S . P S Y C H – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
RAPIDFIRE
ROUNDD B V S . P S Y C H . – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
O f f i c i a l p r e s e n t a t i o n DA N I S H B H AT T I / M O V E M E N T D I S O R D E R S C O .
OUR ATTEMPT ATHIGH NOTE
CLOSER(STUFF THAT REALLY
MATTERS) D B V S . P S Y C H . – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
O f f i c i a l p r e s e n t a t i o n DA N I S H B H AT T I / M O V E M E N T D I S O R D E R S C O .
never, everin your l i fetime
or anybody's l i fetimegive a dopamine antagonist
to a parkinson patient
Myoclonus think SSHigh CK think NMS, MH
Hyper ref lexia think SS, PAIDLeukocytosis think NMS
Peak 12 hours think NMS
t ics are often non-disruptive and don’t need treatment
most of morbidity is usual ly f rom associated behavior
and cognitive problems
SHORTCASES
D B V S . T R E M O R – “ A L L T H A T S H A K E S I S N O T E T ” – M O V E M E N T D I S O R D E R S L E C T U R E S E R I E S
N O V E M B E R 1 1 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
O f f i c i a l p r e s e n t a t i o n DA N I S H B H AT T I / M O V E M E N T D I S O R D E R S C O .
JUSTBECAUSE:
D B V S . P S Y C H . – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .
O f f i c i a l p r e s e n t a t i o n DA N I S H B H AT T I / M O V E M E N T D I S O R D E R S C O .
THANK YOU!
O f f i c i a l p r e s e n t a t i o n DA N I S H B H AT T I / M O V E M E N T D I S O R D E R S C O .
D B V S . P S Y C H . – B O A R D R E V I E W L E C T U R E S E R I E S - “ M O V E M E N T D I S O R D E R S ”
D E C E M B E R 2 , 2 0 1 5 – U N M C – O M A H A , N E , U . S . A .